Analyst Ratings for NovoCure Ltd. (NVCR)
NVCR Rating Summary
NVCR Price Target Summary
- Highest: $47.00 (H.C. Wainwright)
- Lowest: $17.00 (JPMorgan)
- Average: $25.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$25.83 (+62.3%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 68%
Avg. $ Target:
$25.83 (+62.3%)
* Over Last 12-Mos
Rating Score: 6.5 / 10
Percentile Rank: 68%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/13/2026 | JPMorgan | Jessica Fye | New Coverage | Neutral (N/A) |
17.00 (N/A) |
17.29 (15.92) |
-7.92% | Details |
| 7/25/2025 | Wells Fargo » Updated 5/4/2026 |
Larry Biegelsen | Downgrade | Equal Weight (Overweight) |
17.00 (13.50) |
16.51 (15.92) |
-3.57% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
